Progress of autologous hematopoietic stem cell transplantation for malignant lymphoma treatment

VernacularTitle:自体造血干细胞移植治疗恶性淋巴瘤的研究进展
Author: Kemeng SUN ¹ ; Zhiling YAN ; Wei SANG
Author Information

1. 221002,徐州医学院附属医院血液科
Keywords: Lymphoma; Hematopoietic stem cell transplantation; Prognosis
From: Journal of Leukemia & Lymphoma 2017;26(12):765-768
CountryChina
Language:Chinese
Abstract: Autologous hematopoietic stem cell transplantation (AHSCT) is an important method for treatment of malignant lymphoma. Its treatment process is relatively complex, and the curative effect can be affected by many factors. AHSCT has been widely applied in different subtypes of ML treatment, and looking for effective prognostic factors to further differentiate patients who may benefit from AHSCT and formulating reasonable transplantation are important issues for the clinical doctors to deal with. This article briefly reviews the clinical progress of AHSCT for ML treatment.